Journals / İstanbul Kuzey Klinikleri / 2017 / Cilt: 4 - Sayı: 2

Investigation of celiac disease followed by immune thrombocytopenic purpura diagnosis in patients and comparison with literature

Pages
160–164
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No significant difference was found.CONCLUSION: Although it is not necessary to perform CD test in every case of ITP, the presence of differential diagnosis of CD is important to prevent unnecessary treatment, especially in ITP patients with growth retardation or malabsorption findings.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Celiac disease (CD) and Immune thrombocytopenic purpura (ITP) may occur together as a result of similar autoimmune mechanisms.
📊
Key Findings & Data:The aim of this study was to assess the frequency of CD in a group of ITP patients and in the literature.METHODS: A total of 29 patients in Pamukkale University Faculty of Medicine Hospital Pediatric Hematology and Oncology Department with ITP were included in the study.
💡
Conclusion & Impact:No significant difference was found.CONCLUSION: Although it is not necessary to perform CD test in every case of ITP, the presence of differential diagnosis of CD is important to prevent unnecessary treatment, especially in ITP patients with growth retardation or malabsorption findings.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Celiac disease (CD) and Immune thrombocytopenic purpura (ITP) may occur together as a result of similar autoimmune mechanisms. The aim of this study was to assess the frequency of CD in a group of ITP patients and in the literature.METHODS: A total of 29 patients in Pamukkale University Faculty of Medicine Hospital Pediatric Hematology and Oncology Department with ITP were included in the study. Test was performed for the antibodies related to CD. Positive result for celiac antibodies was confirmed with biopsy. The results were compared with the literature.RESULTS: Of the study group, 13 patients (44.8%) were female and 16 (55.2%) were male. The mean age was 7.2±4.7 years and mean platelet count at the time of admission was 13,440±11,110/mm3 (range: 2000-41,000/mm3). Twelve patients (41.4%) were diagnosed as acute ITP, 6 patients (20.7%) as persistent ITP, and 11 patients (37.9%) as chronic ITP, according to the duration of thrombocytopenia. Antibody positivity was detected in 1 patient. Histological evaluation was compatible with CD. Results were compared with studies regarding the prevalence of CD in the population. No significant difference was found.CONCLUSION: Although it is not necessary to perform CD test in every case of ITP, the presence of differential diagnosis of CD is important to prevent unnecessary treatment, especially in ITP patients with growth retardation or malabsorption findings.

🔖

Cite This Article

KOCAMAZ, H., OZHAN, B., AKİN, M., SARBAY, H. (2022). Investigation of celiac disease followed by immune thrombocytopenic purpura diagnosis in patients and comparison with literature. İstanbul Kuzey Klinikleri, Cilt: 4 - Sayı: 2, 160–164. https://ajindex.com/articles/551561

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Celkan T. Changes in chilhood ITP treatment and follow-up in 2011. Turk Pediatri Ars 2012;47:8-17
  2. Bussel J. Disorders of platelets. In: Lanzkowsky P, editor. Manual of pediatric hematology and oncology. 5th ed. San Diego: Elsevier Academic Press; 2011: 321-77
  3. Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005;40:1-19
  4. Mehta G, Taslaq S, Littleford S, Bansi DS, Thillainayagam A. The changing face of coeliac disease. Br J Hosp Med (Lond) 2008;69:84-7
  5. Cataldo F, Marino V. Increased prevalence of autoimmune diseases in first-degree relatives of patients with celiac disease. J Pediatr Gastroenterol Nutr 2003;36:470-3
  6. Lauret E, Rodrigo L. Celiac disease and autoimmune-associated conditions. Biomed Res Int 2013;2013:127589
  7. Fasano A. Clinical presentation of celiac disease in the pediatric population. Gastroenterology 2005;128:S68-73
  8. Halfdanarson TR, Litzow MR, Murray JA. Hematologic manifestations of celiac disease. Blood 2007;109:412-21
  9. Fisgin T, Yarali N, Duru F, Usta B, Kara A. Hematologic manifestation of childhood celiac disease. Acta Haematol 2004;111:211-4
  10. Olén O, Montgomery SM, Elinder G, Ekbom A, Ludvigsson JF. Increased risk of immune thrombocytopenic purpura among inpatients with coeliac disease. Scand J Gastroenterol 2008;43:416-22
  11. Stepniak D, Koning F. Celiac disease-sandwiched between innate and adaptive immunity. Hum Immunol 2006;67:460-8
  12. Zanoni G, Navone R, Lunardi C, Tridente G, Bason C, Sivori S, et al. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med 2006;3:e358
  13. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factoralpha production in vivo. Blood 2006;107:637-41
  14. Biagi F, Klersy C, Balduzzi D, Corazza GR. Are we not overestimating the prevalence of coeliac disease in the general population? Ann Med 2010;42:557-61
  15. Dalgic B, Sari S, Basturk B, Ensari A, Egritas O, Bukulmez A, et al; Turkish Celiac Study Group. Prevalence of celiac disease in healthy Turkish school c